Supporting Research Clinical trials - including three large-scale 68-week studies - have shown that adults without diabetes, when treated with semaglutide alongside a reduced-calorie diet and increased physical activity, achieved significant weight loss compared to placebo groups
Studies on GSTO1-1 also suggested a protective effect of this enzyme on PD, exerted through the inhibition of the active form of interleukin-1 (IL-1 ) which is a critical factor in inflammatory response 47,58
doi: 10.1002/(sici)1096-9861(19990111)403:2 3.0.co;2-5 35 HolstJJ
Let's take a look at the roads that sit before you
Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al